Table 1. Characteristics of the study groups.
Characteristics Group I
(coarse granules in the PVS)
n=41
Group II
(moderately coarse granules in the PVS)
n=20
Group III
(control group)
n=60
p-value
Age, years 32.90 (±5.08) 31.83 (±4.21) 32.48 (±4.85) 0.661
BMI, kg/m2 27.53 (±5.79) 25.98 (±4.26) 25.72 (±5.24) 0.375
FSH, mIU/mL 8.10 (±5.56) 7.02 (±2.35) 7.51 (±2.84) 0.477
LH, mIU/mL 6.71 (±2.90) 6.96 (±3.71) 6.85 (±7.53) 0.987
E2, pg/mL 51.72 (±23.57) 54.47 (±36.81) 53.16 (±27.43) 0.944
Total gonadotropin dose, IU/ml 2530.58 (±1204.63) 2303.54 (±658.93) 2359.02 (±707.53) 0.574
Total antagonist dose, mg 1.21 (±0.35) 1.06 (±0.28) 1.03 (±0.35) 0.085
Duration of antagonist administration, days), n 4.85 (±1.39) 4.21 (±1.13) 4.10 (±1.39) 0.085
MII, n 5.90 (±5.14) 6.76 (±4.23) 5.65 (±3.39) 0.397
Immature oocytes*, n 0.60 (±0.99) 0.90 (±1.32) 0.65 (±1.00) 0.464
Fertilization, % 62.98 (±33.92) 66.63 (±29.79) 72.67 (±23.36) 0.317
D3 good-quality embryos, n 2.41 (±3.18) 3.64 (±3.03) 3.84 (±2.45) 0.193
D3 low-quality embryos, n 0.24 (±0.56) 0.54 (±0.99) 0.04 (±0.21) 0.006
Arrested Embryos, n 0.59 (±1.23) 0.55 (±0.81) 0.00 < 0.001
Implantation (yes), % 16.7 22.9 23.3 0.830
Clinical pregnancy, (yes) % 16.7 22.9 23.3 0.830
Abortus, (yes), % 16.7 5.7 1.7 0.045
Live birth, (yes), % 0 75.0 85.7 0.011

Values are expressed as mean ± standard deviation (SD). P values are obtained by ANOVA or chi-squared tests. A p-value < 0.05 is considered statistically significant. Hormone levels represent the baseline level measured on day three of menstruation. BMI, body mass index; FSH, follicle stimulating hormone; LH, luteinizing hormone; E2, estradiol; MII, metaphase II; D3, developmental day three. *Immature oocytes include both germinal vesicle and metaphase I oocytes. #Arrested embryos represent the total number of arrested embryos up to day three of development.